Recent Company News

• 06:12 PM ET Jun 30, 2025
  

  Biophytis delays publishing annual accounts, will publish by 7-Jul at the latest (€0.13, 0.00)

• 05:00 PM ET Jun 19, 2025
  

  Trading in Biophytis suspended by Euronext due to non-publication of its annual financial report (€0.13, 0.00)

• 04:04 PM ET May 30, 2025
  

  Biophytis further postpones publication of 2024 financial statements; now expects to publish by end of June (€0.13, 0.00)

• 12:02 PM ET Apr 25, 2025
  

  Biophytis postpones publication of its annual financial statements; targets publication by end of May (€0.17, 0.00)

• 01:01 AM ET Apr 09, 2025
  

  Biophytis confirms the launch of the Phase 2 OBA clinical trial in obesity (€0.19, 0.00)

• 05:17 AM ET Mar 17, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:46 AM ET Mar 26, 2025
  

  Biophytis completes €2.6M private placement (€0.31, 0.00)

• 02:40 AM ET Mar 24, 2025
  

  Biophytis announces new preclinical results for its investigational drug BIO101 (€0.30, 0.00)